186 related articles for article (PubMed ID: 31823151)
1. Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei.
Hiraide S; Komine K; Sato Y; Ouchi K; Imai H; Saijo K; Takahashi M; Takahashi S; Shirota H; Takahashi M; Ishioka C
Int J Clin Oncol; 2020 Apr; 25(4):774-781. PubMed ID: 31823151
[TBL] [Abstract][Full Text] [Related]
2. FOLFOX-4 chemotherapy for patients with unresectable or relapsed peritoneal pseudomyxoma.
Pietrantonio F; Maggi C; Fanetti G; Iacovelli R; Di Bartolomeo M; Ricchini F; Deraco M; Perrone F; Baratti D; Kusamura S; Tamborini E; Castano A; Consonni PV; Bossi I; Gavazzi C; Milione M; Pelosi G; de Braud F
Oncologist; 2014 Aug; 19(8):845-50. PubMed ID: 24951608
[TBL] [Abstract][Full Text] [Related]
3. [A case of pseudomyxoma peritonei successfully treated with multidisciplinary treatment including modified FOLFOX6 regimen].
Ishibashi K; Sobajima J; Okada N; Ishizuka N; Yokoyama M; Mitsuhashi T; Miyazaki T; Nakada H; Gonda T; Ishida H
Gan To Kagaku Ryoho; 2007 Nov; 34(12):2047-9. PubMed ID: 18219894
[TBL] [Abstract][Full Text] [Related]
4. A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei.
Farquharson AL; Pranesh N; Witham G; Swindell R; Taylor MB; Renehan AG; Rout S; Wilson MS; O'Dwyer ST; Saunders MP
Br J Cancer; 2008 Aug; 99(4):591-6. PubMed ID: 18682713
[TBL] [Abstract][Full Text] [Related]
5. Experience with adjuvant chemotherapy for pseudomyxoma peritonei secondary to mucinous adenocarcinoma of the appendix with oxaliplatin/fluorouracil/leucovorin (FOLFOX4).
Chen CF; Huang CJ; Kang WY; Hsieh JS
World J Surg Oncol; 2008 Nov; 6():118. PubMed ID: 19014441
[TBL] [Abstract][Full Text] [Related]
6. Therapy of pseudomyxoma peritonei of appendiceal origin--surgical resection and intraperitoneal chemotherapy.
Hosch WP; Rudi J; Stremmel W
Z Gastroenterol; 1999 Jul; 37(7):615-22. PubMed ID: 10458011
[TBL] [Abstract][Full Text] [Related]
7. Metronomic Capecitabine With Cyclophosphamide Regimen in Unresectable or Relapsed Pseudomyxoma Peritonei.
Raimondi A; Corallo S; Niger M; Antista M; Randon G; Morano F; Milione M; Kusamura S; Baratti D; Guaglio M; Cremolini C; Marmorino F; Di Bartolomeo M; Deraco M; De Braud F; Pietrantonio F
Clin Colorectal Cancer; 2019 Jun; 18(2):e179-e190. PubMed ID: 31023524
[TBL] [Abstract][Full Text] [Related]
8. Successful antiangiogenic combination therapy for pseudomyxoma peritonei with bevacizumab and capecitabine.
Sun WL; Hutarew G; Gradl J; Gratzl M; Denz H; Fiegl M
Cancer Biol Ther; 2009 Aug; 8(15):1459-62. PubMed ID: 19483475
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of complete cytoreductive surgery and two intraperitoneal chemotherapy techniques in Pseudomyxoma peritonei.
Sørensen O; Flatmark K; Reed W; Wiig JN; Dueland S; Giercksky KE; Larsen SG
Eur J Surg Oncol; 2012 Oct; 38(10):969-76. PubMed ID: 22763244
[TBL] [Abstract][Full Text] [Related]
10. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Nonaka D; Langer M; Andreola S; Favaro M; Gavazzi C; Laterza B; Deraco M
Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976
[TBL] [Abstract][Full Text] [Related]
11. Hyperthermic intraperitoneal chemotherapy with oxaliplatin as treatment for peritoneal carcinomatosis arising from the appendix and pseudomyxoma peritonei: a survival analysis.
Marcotte E; Dubé P; Drolet P; Mitchell A; Frenette S; Leblanc G; Leclerc YE; Sideris L
World J Surg Oncol; 2014 Nov; 12():332. PubMed ID: 25380618
[TBL] [Abstract][Full Text] [Related]
12. Drug Sensitivity Testing in Cytoreductive Surgery and Intraperitoneal Chemotherapy of Pseudomyxoma Peritonei.
Bjersand K; Mahteme H; Sundström Poromaa I; Andréasson H; Graf W; Larsson R; Nygren P
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S810-6. PubMed ID: 26193962
[TBL] [Abstract][Full Text] [Related]
13. Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Elias D; Honoré C; Ciuchendéa R; Billard V; Raynard B; Lo Dico R; Dromain C; Duvillard P; Goéré D
Br J Surg; 2008 Sep; 95(9):1164-71. PubMed ID: 18690633
[TBL] [Abstract][Full Text] [Related]
14. Improved Survival with Anti-VEGF Therapy in the Treatment of Unresectable Appendiceal Epithelial Neoplasms.
Choe JH; Overman MJ; Fournier KF; Royal RE; Ohinata A; Rafeeq S; Beaty K; Phillips JK; Wolff RA; Mansfield PF; Eng C
Ann Surg Oncol; 2015 Aug; 22(8):2578-84. PubMed ID: 25582740
[TBL] [Abstract][Full Text] [Related]
15. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
[TBL] [Abstract][Full Text] [Related]
16. Impact of a modified peritoneal cancer index using FDG-PET/CT (PET-PCI) in predicting tumor grade and progression-free survival in patients with pseudomyxoma peritonei.
Hotta M; Minamimoto R; Gohda Y; Igari T; Yano H
Eur Radiol; 2019 Oct; 29(10):5709-5716. PubMed ID: 30874878
[TBL] [Abstract][Full Text] [Related]
17. Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Arising from Urachus.
Liu Y; Ishibashi H; Hirano M; Takeshita K; Mizumoto A; Ichinose M; Nishino E; Kashu I; Yamamoto Y; Sugarbaker PH; Yonemura Y
Ann Surg Oncol; 2015 Aug; 22(8):2799-805. PubMed ID: 25572681
[TBL] [Abstract][Full Text] [Related]
18. Modified FOLFOX6 chemotherapy in patients with metastatic urachal cancer.
Yanagihara Y; Tanji N; Miura N; Shirato A; Nishimura K; Fukumoto T; Azuma K; Miyauchi Y; Kikugawa T; Yokoyama M
Chemotherapy; 2013; 59(6):402-6. PubMed ID: 24969043
[TBL] [Abstract][Full Text] [Related]
19. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.
Sugarbaker PH
Eur J Surg Oncol; 2001 Apr; 27(3):239-43. PubMed ID: 11373099
[TBL] [Abstract][Full Text] [Related]
20. Identifying prognostic factors in Japanese women with pseudomyxoma peritonei: a retrospective clinico-pathological study of the Tohoku Gynecologic Cancer Unit.
Kojimahara T; Nakahara K; Shoji T; Sugiyama T; Takano T; Yaegashi N; Yokoyama Y; Mizunuma H; Tase R; Satou H; Tanaka T; Motoyama T; Kurachi H
Tohoku J Exp Med; 2011 Feb; 223(2):91-6. PubMed ID: 21263209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
